jain.com

$15 million convertible promissory note advance

Company: TeraWulf

This claim was marked delayed on September 15, 2026. Recorded automatically from the cited source when it was published, then queued for evidence review.

How this was decided: Automated extraction from the cited source. The claim is preserved below exactly as it was originally published, so the record shows what was asserted as well as what became of it.

Subject kind
financing
Statement date
2022-06-07
Promised by
2022-11-25
Promised amount
15000000.0 USD
Current status
delayed

The claim, verbatim

Received $15 million principal convertible promissory note at 4% annual interest, convertible at $3.75 per share, maturing November 25, 2022

Source (primary)

TeraWulf 8-K filed 2022-06-08 (SEC EDGAR, sec_filing)
View cached copy (2026-09-13)Live source ↗

Quote: “the Company received an advance from Yorkville in the form of a convertible promissory note in an aggregate principal amount of $15 million... The Advance has a maturity date of November 25, 2022... and accrues annual interest at a rate of 4%... at a conversion price of $3.75”

How we checked this

This claim has not yet been checked assertion-by-assertion against its source. It carries a cited source and quote, but the deeper check has not run. When it does, the result appears here whatever it says.

Additional evidence

confirms TeraWulf 8-K filed 2022-06-08

Quote: “the Company received an advance from Yorkville in the form of a convertible promissory note in an aggregate principal amount of $15 million... The Advance has a maturity date of November 25, 2022... and accrues annual interest at a rate of 4%... at a conversion price of $3.75”

View cached copy (2026-09-13)Live source ↗

Record of changes

September 14, 2026 — stated
Automated extraction from the cited source. Recorded automatically from the cited source when it was published, then queued for evidence review.
September 15, 2026 — delayed
Automated extraction from the cited source. Recorded automatically from the cited source when it was published, then queued for evidence review.